Aug 14 (Reuters) - PDS Biotechnology Corp PDSB.O :
* PDS BIOTECH REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
* PDS BIOTECHNOLOGY CORP Q2 LOSS PER SHARE $0.37
* PDS BIOTECHNOLOGY CORP Q2 EARNINGS PER SHARE VIEW $-0.35
--
REFINITIV IBES DATA
* PDS BIOTECHNOLOGY CORP - CASH AND CASH EQUIVALENTS AS OF
JUNE
30, 2023, TOTALED ABOUT $60.6 MILLION
* PDS BIOTECHNOLOGY- BELIEVES CASH AMOUNT IS SUFFICIENT TO
FUND
OPERATIONS & RESEARCH AND DEVELOPMENT PROGRAMS FOR 12 MONTHS
FOLLOWING FILING OF JUNE 2023 QUARTERLY REPORT
Source text for Eikon: ID:nGNXbmRvpr
Further company coverage: PDSB.O
((Reuters.Briefs@thomsonreuters.com;))